Torben Lund-Hansen - Aug 28, 2024 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
SVP & CHIEF TECHNICAL OFFICER
Signature
/s/ John LaRocca, Attorney-in-Fact
Stock symbol
YMAB
Transactions as of
Aug 28, 2024
Transactions value $
-$549,500
Form type
4
Date filed
8/30/2024, 04:15 PM
Previous filing
Jan 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Options Exercise $219K +50K +140.45% $4.38 85.6K Aug 28, 2024 Direct
transaction YMAB Common Stock Sale -$769K -50K -58.41% $15.37 35.6K Aug 28, 2024 Direct F1
holding YMAB Common Stock 45.7K Aug 28, 2024 By Toluha ApS F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction YMAB Employee Stock Option (right to buy) Options Exercise $0 -50K -33.33% $0.00 100K Aug 28, 2024 Common Stock 50K $4.38 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $15.00 to $15.6978, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Reporting Person is sole member of Toluha ApS.
F3 Stock options are fully vested.